CDK1 and hepatocellular carcinoma: In addition, survival curves for HCC patients with different tumor stages were also plotted, which showed that the high CDK1 predicts poor overall survival in patients with tumor stage 2 (log-rank P = 0.0016, Figure 3(i)) and tumor stage 3 (log-rank P = 0.013, Figure 3(j)).